Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

Yigit, 2001, Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae, Antimicrob Agents Chemother, 45, 1151, 10.1128/AAC.45.4.1151-1161.2001 Papp-Wallace, 2010, Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase, Antimicrob Agents Chemother, 54, 890, 10.1128/AAC.00693-09 Bradford, 2004, Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 beta-lactamases in New York City, Clin Infect Dis, 39, 55, 10.1086/421495 Chiang, 2007, Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey, Microb Drug Resist, 13, 235, 10.1089/mdr.2007.767 Pope, 2006, KPC type beta-lactamase, rural Pennsylvania, Emerg Infect Dis, 12, 1613, 10.3201/eid1210.060297 Hossain, 2004, Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter sp, Antimicrob Agents Chemother, 48, 4438, 10.1128/AAC.48.11.4438-4440.2004 Smith, 2003, Plasmid-mediated, carbapenem-hydrolysing beta-lactamase, KPC-2, in Klebsiella pneumoniae isolates, J Antimicrob Chemother, 51, 711, 10.1093/jac/dkg124 2013, Vital signs: carbapenem-resistant enterobacteriaceae, MMWR Morb Mortal Wkly Rep, 62, 165 Kitchel, 2009, Molecular epidemiology of KPC-producing Klebsiella pneumoniae isolates in the United States: clonal expansion of multilocus sequence type 258, Antimicrob Agents Chemother, 53, 3365, 10.1128/AAC.00126-09 Navon-Venezia, 2009, First report on a hyperepidemic clone of KPC-3-producing Klebsiella pneumoniae in Israel genetically related to a strain causing outbreaks in the United States, Antimicrob Agents Chemother, 53, 818, 10.1128/AAC.00987-08 Won, 2011, Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae, Clin Infect Dis, 53, 532, 10.1093/cid/cir482 Tibbetts, 2008, Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC beta-lactamase in P mirabilis, J Clin Microbiol, 46, 3080, 10.1128/JCM.00979-08 Rasheed, 2008, Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K oxytoca carrying a common plasmid, J Clin Microbiol, 46, 2066, 10.1128/JCM.02038-07 Bratu, 2005, Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York, Antimicrob Agents Chemother, 49, 776, 10.1128/AAC.49.2.776-778.2005 Robledo, 2011, Detection of the KPC gene in Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, and Acinetobacter baumannii during a PCR-based nosocomial surveillance study in Puerto Rico, Antimicrob Agents Chemother, 55, 2968, 10.1128/AAC.01633-10 Poirel, 2010, Emergence of KPC-producing Pseudomonas aeruginosa in the United States, Antimicrob Agents Chemother, 54, 3072, 10.1128/AAC.00513-10 Bennett, 2009, KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient, Antimicrob Agents Chemother, 53, 292, 10.1128/AAC.00931-08 Chitnis, 2012, Outbreak of carbapenem-resistant Enterobacteriaceae at a long-term acute care hospital: sustained reductions in transmission through active surveillance and targeted interventions, Infect Control Hosp Epidemiol, 33, 984, 10.1086/667738 Viau, 2012, “Silent” dissemination of Klebsiella pneumoniae isolates bearing K pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio, Clin Infect Dis, 54, 1314, 10.1093/cid/cis036 Endimiani, 2009, Emergence of blaKPC-containing Klebsiella pneumoniae in a long-term acute care hospital: a new challenge to our healthcare system, J Antimicrob Chemother, 64, 1102, 10.1093/jac/dkp327 Prabaker, 2012, Transfer from high acuity long-term care facilities is associated with carriage of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae: a multi-hospital study, Infect Control Hosp Epidemiol, 33, 1193, 10.1086/668435 Munoz-Price, 2010, Successful control of an outbreak of Klebsiella pneumoniae carbapenemase-producing K pneumoniae at a long-term acute care hospital, Infect Control Hosp Epidemiol, 31, 341, 10.1086/651097 Gasink, 2009, Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K pneumoniae, Infect Control Hosp Epidemiol, 30, 1180, 10.1086/648451 Patel, 2008, Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies, Infect Control Hosp Epidemiol, 29, 1099, 10.1086/592412 Snitkin, 2012, Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing, Sci Transl Med, 4, 148ra116, 10.1126/scitranslmed.3004129 2009, Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities, MMWR Morb Mortal Wkly Rep, 58, 256 Pillai, 2009, Klebsiella pneumoniae carbapenemase, Canada, Emerg Infect Dis, 15, 827, 10.3201/eid1505.081536 Goldfarb, 2009, Detection of plasmid-mediated KPC-producing Klebsiella pneumoniae in Ottawa, Canada: evidence of intrahospital transmission, J Clin Microbiol, 47, 1920, 10.1128/JCM.00098-09 Chan, 2013, The characteristics of Klebsiella pneumoniae that produce KPC-2 imported from Greece, Diagn Microbiol Infect Dis, 75, 317, 10.1016/j.diagmicrobio.2012.12.003 Mataseje, 2012, Carbapenem-resistant Gram-negative bacilli in Canada 2009–10: results from the Canadian Nosocomial Infection Surveillance Program (CNISP), J Antimicrob Chemother, 67, 1359, 10.1093/jac/dks046 Mojica, 2012, Molecular correlates of the spread of KPC-producing Enterobacteriaceae in Colombia, Int J Antimicrob Agents, 40, 277, 10.1016/j.ijantimicag.2012.05.006 Villegas, 2006, First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America, Antimicrob Agents Chemother, 50, 2880, 10.1128/AAC.00186-06 Villegas, 2007, First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase, Antimicrob Agents Chemother, 51, 1553, 10.1128/AAC.01405-06 Lopez, 2011, Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain, Clin Microbiol Infect, 17, 52, 10.1111/j.1469-0691.2010.03209.x Cuzon, 2011, Wide dissemination of Pseudomonas aeruginosa producing beta-lactamase blaKPC-2 gene in Colombia, Antimicrob Agents Chemother, 55, 5350, 10.1128/AAC.00297-11 Gales, 2012, Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008–2010), Diagn Microbiol Infect Dis, 73, 354, 10.1016/j.diagmicrobio.2012.04.007 Pasteran, 2008, Klebsiella pneumoniae carbapenemase-2, Buenos Aires, Argentina, Emerg Infect Dis, 14, 1178, 10.3201/eid1407.070826 Gomez, 2011, Clonal dissemination of Klebsiella pneumoniae ST258 harbouring KPC-2 in Argentina, Clin Microbiol Infect, 17, 1520, 10.1111/j.1469-0691.2011.03600.x Pasteran, 2012, Detection of an international multiresistant clone belonging to sequence type 654 involved in the dissemination of KPC-producing Pseudomonas aeruginosa in Argentina, J Antimicrob Chemother, 67, 1291, 10.1093/jac/dks032 Monteiro, 2009, First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil, Antimicrob Agents Chemother, 53, 333, 10.1128/AAC.00736-08 Seki, 2011, Molecular epidemiology of KPC-2-producing Klebsiella pneumoniae isolates in Brazil: the predominance of sequence type 437, Diagn Microbiol Infect Dis, 70, 274, 10.1016/j.diagmicrobio.2011.01.006 Chagas, 2011, Occurrence of KPC-2-producing Klebsiella pneumoniae strains in hospital wastewater, J Hosp Infect, 77, 281, 10.1016/j.jhin.2010.10.008 Jacome, 2012, First report of KPC-producing Pseudomonas aeruginosa in Brazil, Antimicrob Agents Chemother, 56, 4990, 10.1128/AAC.00699-12 Almeida, 2012, First description of KPC-2-producing Pseudomonas putida in Brazil, Antimicrob Agents Chemother, 56, 2205, 10.1128/AAC.05268-11 Livermore, 2008, Non-susceptibility trends among Pseudomonas aeruginosa and other non-fermentative Gram-negative bacteria from bacteraemias in the UK and Ireland, 2001–06, J Antimicrob Chemother, 62, ii55 Woodford, 2008, Arrival of Klebsiella pneumoniae producing KPC carbapenemase in the United Kingdom, J Antimicrob Chemother, 62, 1261, 10.1093/jac/dkn396 Livermore, 2012, Fourteen years in resistance, Int J Antimicrob Agents, 39, 283, 10.1016/j.ijantimicag.2011.12.012 Roche, 2009, First identification of class A carbapenemase-producing Klebsiella pneumoniae in the Republic of Ireland, Euro Surveill, 14, 19163, 10.2807/ese.14.13.19163-en Morris, 2012, Inter-hospital outbreak of Klebsiella pneumoniae producing KPC-2 carbapenemase in Ireland, J Antimicrob Chemother, 67, 2367, 10.1093/jac/dks239 Curiao, 2010, Emergence of bla KPC-3-Tn4401a associated with a pKPN3/4-like plasmid within ST384 and ST388 Klebsiella pneumoniae clones in Spain, J Antimicrob Chemother, 65, 1608, 10.1093/jac/dkq174 Gomez-Gil, 2010, Detection of KPC-2-producing Citrobacter freundii isolates in Spain, J Antimicrob Chemother, 65, 2695, 10.1093/jac/dkq352 Poirel, 2012, Environmental KPC-producing Escherichia coli isolates in Portugal, Antimicrob Agents Chemother, 56, 1662, 10.1128/AAC.05850-11 Naas, 2005, Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC in a Klebsiella pneumoniae isolate from France, Antimicrob Agents Chemother, 49, 4423, 10.1128/AAC.49.10.4423-4424.2005 Dortet, 2008, Intercontinental travels of patients and dissemination of plasmid-mediated carbapenemase KPC-3 associated with OXA-9 and TEM-1, J Antimicrob Chemother, 61, 455, 10.1093/jac/dkm455 Cuzon, 2008, Plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece, Antimicrob Agents Chemother, 52, 796, 10.1128/AAC.01180-07 Petrella, 2008, Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A beta-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France, Antimicrob Agents Chemother, 52, 3725, 10.1128/AAC.00163-08 Potron, 2012, Importation of KPC-2-producing Escherichia coli from India, J Antimicrob Chemother, 67, 242, 10.1093/jac/dkr426 Naas, 2011, When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France, Antimicrob Agents Chemother, 55, 4933, 10.1128/AAC.00719-11 Rogers, 2011, Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain, J Antimicrob Chemother, 66, 1, 10.1093/jac/dkq415 Cuzon, 2012, Nosocomial outbreak of Klebsiella pneumoniae harbouring bla(KPC-3) in France subsequent to a patient transfer from Italy, Int J Antimicrob Agents, 39, 448, 10.1016/j.ijantimicag.2012.01.008 Naas, 2010, Endoscopy-associated transmission of carbapenem-resistant Klebsiella pneumoniae producing KPC-2 beta-lactamase, J Antimicrob Chemother, 65, 1305, 10.1093/jac/dkq117 Giani, 2009, Emergence in Italy of Klebsiella pneumoniae sequence type 258 producing KPC-3 carbapenemase, J Clin Microbiol, 47, 3793, 10.1128/JCM.01773-09 Fontana, 2010, Emergence of KPC-producing Klebsiella pneumoniae in Italy, BMC Res Notes, 3, 40, 10.1186/1756-0500-3-40 Richter, 2012, KPC-mediated resistance in Klebsiella pneumoniae in two hospitals in Padua, Italy, June 2009–December 2011: massive spreading of a KPC-3-encoding plasmid and involvement of non-intensive care units, Gut Pathog, 4, 7, 10.1186/1757-4749-4-7 Mazzariol, 2012, Rapid molecular technique analysis of a KPC-3-producing Klebsiella pneumoniae outbreak in an Italian surgery unit, J Chemother, 24, 93, 10.1179/1120009X12Z.00000000020 Mammina, 2012, Ongoing spread of colistin-resistant Klebsiella pneumoniae in different wards of an acute general hospital, Italy, June to December 2011, Euro Surveill, 17, 10.2807/ese.17.33.20248-en Sisto, 2012, Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012, Euro Surveill, 17, 10.2807/ese.17.33.20247-en Baraniak, 2009, Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Poland, Antimicrob Agents Chemother, 53, 4565, 10.1128/AAC.00436-09 Baraniak, 2011, Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008–2009, Antimicrob Agents Chemother, 55, 5493, 10.1128/AAC.05118-11 Tegmark, 2007, Identification of Klebsiella pneumoniae carbapenemase in Sweden, Euro Surveill, 12, E071220 Maltezou, 2009, Outbreak of infections due to KPC-2-producing Klebsiella pneumoniae in a hospital in Crete (Greece), J Infect, 58, 213, 10.1016/j.jinf.2009.01.010 Pournaras, 2009, Clonal spread of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains in Greece, J Antimicrob Chemother, 64, 348, 10.1093/jac/dkp207 Souli, 2010, An outbreak of infection due to beta-lactamase Klebsiella pneumoniae carbapenemase 2-producing K pneumoniae in a Greek University Hospital: molecular characterization, epidemiology, and outcomes, Clin Infect Dis, 50, 364, 10.1086/649865 Kontopoulou, 2010, Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 beta-lactamase resistant to colistin, J Hosp Infect, 76, 70, 10.1016/j.jhin.2010.03.021 Zarkotou, 2011, Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment, Clin Microbiol Infect, 17, 1798, 10.1111/j.1469-0691.2011.03514.x Maltezou HC, Kontopidou F, Dedoukou X, et al. National action plan to combat infections due to carbapenem-resistant, Gram-negative pathogens in acute-care hospitals in Greece. J Global Antimicrob Resist (in press). Mavroidi, 2012, Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 beta-lactamase, Int J Antimicrob Agents, 39, 247, 10.1016/j.ijantimicag.2011.11.003 Wernli, 2011, A call for action: the application of the international health regulations to the global threat of antimicrobial resistance, PLoS Med, 8, e1001022, 10.1371/journal.pmed.1001022 Van der Bij, 2012, The role of international travel in the worldwide spread of multiresistant Enterobacteriaceae, J Antimicrob Chemother, 67, 2090, 10.1093/jac/dks214 Giakkoupi, 2011, An update of the evolving epidemic of blaKPC-2-carrying Klebsiella pneumoniae in Greece (2009–10), J Antimicrob Chemother, 66, 1510, 10.1093/jac/dkr166 Giakoupi, 2009, KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone, Euro Surveill, 14 Marchaim, 2008, Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes, Antimicrob Agents Chemother, 52, 1413, 10.1128/AAC.01103-07 Schwaber, 2011, Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention, Clin Infect Dis, 52, 848, 10.1093/cid/cir025 Schwaber, 2008, Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality, Antimicrob Agents Chemother, 52, 1028, 10.1128/AAC.01020-07 Hussein, 2009, Carbapenem resistance among Klebsiella pneumoniae isolates: risk factors, molecular characteristics, and susceptibility patterns, Infect Control Hosp Epidemiol, 30, 666, 10.1086/598244 Borer, 2009, Attributable mortality rate for carbapenem-resistant Klebsiella pneumoniae bacteremia, Infect Control Hosp Epidemiol, 30, 972, 10.1086/605922 Canton, 2012, Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe, Clin Microbiol Infect, 18, 413, 10.1111/j.1469-0691.2012.03821.x Ben-David, 2011, Carbapenem-resistant Klebsiella pneumoniae in post-acute-care facilities in Israel, Infect Control Hosp Epidemiol, 32, 845, 10.1086/661279 Jones, 2009, Characterization and sequence analysis of extended-spectrum-{beta}-lactamase-encoding genes from Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates collected during tigecycline phase 3 clinical trials, Antimicrob Agents Chemother, 53, 465, 10.1128/AAC.00883-08 Kumarasamy, 2012, Emergence of Klebsiella pneumoniae isolate co-producing NDM-1 with KPC-2 from India, J Antimicrob Chemother, 67, 243, 10.1093/jac/dkr431 Kumarasamy, 2010, Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study, Lancet Infect Dis, 10, 597, 10.1016/S1473-3099(10)70143-2 Castanheira, 2011, Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006–2007, Antimicrob Agents Chemother, 55, 1274, 10.1128/AAC.01497-10 Wei, 2007, Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China, Antimicrob Agents Chemother, 51, 763, 10.1128/AAC.01053-06 Qi, 2011, ST11, the dominant clone of KPC-producing Klebsiella pneumoniae in China, J Antimicrob Chemother, 66, 307, 10.1093/jac/dkq431 Li, 2011, Novel genetic environment of the plasmid-mediated KPC-3 gene detected in Escherichia coli and Citrobacter freundii isolates from China, Eur J Clin Microbiol Infect Dis, 30, 575, 10.1007/s10096-010-1124-7 Zhang, 2012, Enterobacteriaceae producing the KPC-2 carbapenemase from hospital sewage, Diagn Microbiol Infect Dis, 73, 204, 10.1016/j.diagmicrobio.2012.02.007 Ge, 2011, Identification of KPC-2-producing Pseudomonas aeruginosa isolates in China, J Antimicrob Chemother, 66, 1184, 10.1093/jac/dkr060 Nordmann, 2012, Identification and screening of carbapenemase-producing Enterobacteriaceae, Clin Microbiol Infect, 18, 432, 10.1111/j.1469-0691.2012.03815.x Hrabak, 2012, Detection of NDM-1, VIM-1, KPC, OXA-48, and OXA-162 carbapenemases by matrix-assisted laser desorption ionization-time of flight mass spectrometry, J Clin Microbiol, 50, 2441, 10.1128/JCM.01002-12 Doyle, 2012, Laboratory detection of Enterobacteriaceae that produce carbapenemases, J Clin Microbiol, 50, 3877, 10.1128/JCM.02117-12 Pournaras, 2010, Inhibitor-based methods for the detection of KPC carbapenemase-producing Enterobacteriaceae in clinical practice by using boronic acid compounds, J Antimicrob Chemother, 65, 1319, 10.1093/jac/dkq124 Wilkinson, 2012, Comparison of four chromogenic culture media for carbapenemase-producing Enterobacteriaceae, J Clin Microbiol, 50, 3102, 10.1128/JCM.01613-12 Girlich, 2013, Comparison of the SUPERCARBA, CHROMagar KPC, and Brilliance CRE screening media for detection of Enterobacteriaceae with reduced susceptibility to carbapenems, Diagn Microbiol Infect Dis, 75, 214, 10.1016/j.diagmicrobio.2012.10.006 Lee, 2012, Treatment of Klebsiella pneumoniae carbapenemase (KPC) infections: a review of published case series and case reports, Ann Clin Microbiol Antimicrob, 11, 32, 10.1186/1476-0711-11-32 Adams-Haduch, 2009, Activity of temocillin against KPC-producing Klebsiella pneumoniae and Escherichia coli, Antimicrob Agents Chemother, 53, 2700, 10.1128/AAC.00290-09 Tzouvelekis, 2012, Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions, Clin Microbiol Rev, 25, 682, 10.1128/CMR.05035-11 Tumbarello, 2012, Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K pneumoniae: importance of combination therapy, Clin Infect Dis, 55, 943, 10.1093/cid/cis588 Qureshi, 2012, Treatment outcome of bacteremia due to KPC-producing Klebsiella pneumoniae: superiority of combination antimicrobial regimens, Antimicrob Agents Chemother, 56, 2108, 10.1128/AAC.06268-11 Kofteridis, 2010, Aerosolized plus intravenous colistin versus intravenous colistin alone for the treatment of ventilator-associated pneumonia: a matched case-control study, Clin Infect Dis, 51, 1238, 10.1086/657242 Livermore, 2011, Activities of NXL104 combinations with ceftazidime and aztreonam against carbapenemase-producing Enterobacteriaceae, Antimicrob Agents Chemother, 55, 390, 10.1128/AAC.00756-10 Livermore, 2011, Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolates, J Antimicrob Chemother, 66, 48, 10.1093/jac/dkq408 Li, 2012, Epidemic of Klebsiella pneumoniae ST11 clone coproducing KPC-2 and 16S rRNA methylase RmtB in a Chinese University Hospital, BMC Infect Dis, 12, 373, 10.1186/1471-2334-12-373 Xiao, 2012, Fluorocyclines. 1. 7-fluoro-9-pyrrolidinoacetamido-6-demethyl-6-deoxytetracycline: a potent, broad spectrum antibacterial agent, J Med Chem, 55, 597, 10.1021/jm201465w Hirsch, 2012, In vitro activity of MK-7655, a novel beta-lactamase inhibitor, in combination with imipenem against carbapenem-resistant Gram-negative bacteria, Antimicrob Agents Chemother, 56, 3753, 10.1128/AAC.05927-11 Page, 2010, In vitro properties of BAL30072, a novel siderophore sulfactam with activity against multiresistant gram-negative bacilli, Antimicrob Agents Chemother, 54, 2291, 10.1128/AAC.01525-09 Mushtaq, 2013, Activity of BAL30072 alone or combined with beta-lactamase inhibitors or with meropenem against carbapenem-resistant Enterobacteriaceae and non-fermenters, J Antimicrob Chemother, 68, 1601, 10.1093/jac/dkt050 Endimiani, 2011, Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniae, Antimicrob Agents Chemother, 55, 82, 10.1128/AAC.01198-10 Munoz-Price, 2013, Deconstructing the infection control bundles for the containment of carbapenem-resistant Enterobacteriaceae, Curr Opin Infect Dis, 26, 378, 10.1097/01.qco.0000431853.71500.77 Kochar, 2009, Success of an infection control program to reduce the spread of carbapenem-resistant Klebsiella pneumoniae, Infect Control Hosp Epidemiol, 30, 447, 10.1086/596734 Gregory, 2010, Outbreak of carbapenem-resistant Klebsiella pneumoniae in Puerto Rico associated with a novel carbapenemase variant, Infect Control Hosp Epidemiol, 31, 476, 10.1086/651670 Ben-David, 2010, Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection, Infect Control Hosp Epidemiol, 31, 620, 10.1086/652528 Munoz-Price, 2010, Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K pneumoniae carbapenemase-producing K pneumoniae outbreak in a surgical intensive care unit in Miami, Florida, Infect Control Hosp Epidemiol, 31, 1074, 10.1086/656243 Ciobotaro, 2011, An effective intervention to limit the spread of an epidemic carbapenem-resistant Klebsiella pneumoniae strain in an acute care setting: from theory to practice, Am J Infect Control, 39, 671, 10.1016/j.ajic.2011.05.004 Borer, 2011, A multifaceted intervention strategy for eradication of a hospital-wide outbreak caused by carbapenem-resistant Klebsiella pneumoniae in Southern Israel, Infect Control Hosp Epidemiol, 32, 1158, 10.1086/662620 Agodi, 2011, Containment of an outbreak of KPC-3-producing Klebsiella pneumoniae in Italy, J Clin Microbiol, 49, 3986, 10.1128/JCM.01242-11 Poulou, 2012, Imported Klebsiella pneumoniae carbapenemase-producing K pneumoniae clones in a Greek hospital: impact of infection control measures for restraining their dissemination, J Clin Microbiol, 50, 2618, 10.1128/JCM.00459-12 Robustillo, 2012, Emergence and outbreak of carbapenemase-producing KPC-3 Klebsiella pneumoniae in Spain, September 2009 to February 2010: control measures, Euro Surveill, 17 Landman, 2012, Transmission of carbapenem-resistant pathogens in New York City hospitals: progress and frustration, J Antimicrob Chemother, 67, 1427, 10.1093/jac/dks063 Poirel, 2012, OXA-48-like carbapenemases: the phantom menace, J Antimicrob Chemother, 67, 1597, 10.1093/jac/dks121 Bogdanovich, 2011, Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258, Clin Infect Dis, 53, 373, 10.1093/cid/cir401